KRN5500 in Treating Patients With Solid Tumors

NCT00017238 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: KRN5500
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)